MedTrace Logo

Pilot Study of Vitamin D Supplementation in Heart Failure

NCT01388855 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2015-06-19

No results posted yet for this study

Summary

The purpose of this study is to determine if the methods are feasible for a larger clinical trial.The study will examine the relationship between vitamin D status, quality of life, pain and walking distance of individuals living with heart failure.

Conditions

Interventions

DRUG

Cholecalciferol

Subjects receive cholecalciferol 20,000 IU daily for 30 days followed by 20,000 IU once weekly for 8 weeks.

DRUG

Placebo

Pills made to look like vitamin D but have no medication in them

Sponsors & Collaborators

  • Fraser Health

    lead OTHER

Principal Investigators

  • Liz C da Silva, MS · Fraser Health Authority

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01388855 on ClinicalTrials.gov